New ultrasound technique could help surgeons see brain activity in real time
NCT ID NCT02656407
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested a new, highly sensitive ultrasound technique to map brain activity during surgery in 23 adults with brain tumors or lesions. The method aims to provide real-time images of blood flow changes linked to brain function, without needing contrast agents. Researchers compared it to standard methods like cortical stimulation mapping and functional MRI to see if it could accurately identify active brain areas.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Ultrasound device (Aixplorer)
- What this could lead to
- If successful, this could provide a cheaper, real-time way to map brain function during surgery, potentially improving surgical precision.
- What could go wrong
- This is a small, early-stage study (23 people) testing a new imaging method. It may not prove better than existing techniques, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAIN LESION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Pitié Salpetriere Hospital
Paris, Île-de-France Region, 75013, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can trained immune cells outsmart brain tumors?
- Digital tests may offer a new way to track brain health in tumor patients
- Mapping the hidden toll of brain radiation on young minds
- Scientists create detailed brain maps to protect language during surgery
- Could a cancer drug shrink recurrent brain tumors?
- Engineered immune cells target deadly brain tumors in children